Physician profile
Daniel R Smith
NPI 1639173024
$1,497.16
in general payments reported to CMS, 2019-2025
16 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $45.31 · 2022: $253 · 2023: $308 · 2024: $356 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $367.48 | 2022-2024 | Inspire |
| Harmony Biosciences LLC | $226.07 | 2022-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $154.22 | 2024 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $144.14 | 2019 | |
| Axsome Therapeutics, INC. | $130.63 | 2023-2025 | Sunosi |
| Philips North America LLC | $105.53 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $74.77 | 2020-2024 | Acthar |
| Amgen INC. | $73.62 | 2022-2023 | Tezspire |
| Jazz Pharmaceuticals INC. | $73.55 | 2023-2025 | |
| Glaxosmithkline, LLC. | $36.61 | 2025 | Nucala |
| Atricure, INC. | $25.58 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Insmed, INC. | $23.00 | 2019-2020 | |
| Genzyme Corporation | $18.56 | 2024 | |
| Vifor Pharma, INC. | $16.89 | 2024 | Zemaira |
| Verona Pharma, INC. | $14.27 | 2025 | Ohtuvayre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.